The Sabin Vaccine Institute Board of Trustees oversees the activities of the Global Network. We are grateful for the activism and generosity of our Board of Trustees, composed of international leaders in business, civil service, academia and philanthropy.
Morton P. Hyman, Chairman
Mr. Hyman was elected Chairman of the Sabin Vaccine Institute in November 2008 and has been an active Trustee since November 2007. Mr. Hyman has extensive experience in the leadership of philanthropic, business and governmental organizations. For over 30 years, he served as President and a Director of Overseas Shipholding Group. He retired from the company in 2003 as Chairman of the Board and CEO.
In 1971, Mr. Hyman was appointed by Governor Nelson Rockefeller to the New York State Public Health Council; he served on the Council for 25 years, including 15 years as Chairman. In 1997, he led the formation and became the first Chair of Continuum Health Partners, one of the largest voluntary hospital systems in the United States. Mr. Hyman graduated with distinction from the Cornell University Law School in (1959) and received his BA from the Cornell University School of Arts and Sciences (1956).
Allan L. Goldstein, PhD, Professor in the Department of Biochemistry & Molecular Biology at The George Washington University School of Medicine
Dr. Goldstein is a Professor in the Department of Biochemistry & Molecular Biology at The George Washington University School of Medicine. He is an authority on the thymus gland and the workings of the immune system, and co-discoverer of the thymosins.
Dr. Goldstein is the author of more than 430 scientific articles, the inventor on over 15 U.S. Patents, and the editor of several books in the field of biochemistry, biomedicine, immunology, and neuroscience. He is the recipient of several awards including decoration in order "Vasco Nunez De Balboa," in the rank of Commander, Panama's highest national honor for "contributions directed to the preservation of human life in the world"; and the "Chevalier des Palmes Academiques," the highest civilian award of France, for scientific contributions. He received a B.S. degree from Wagner College in 1959 and his M.S. and Ph.D. degrees from Rutgers in 1964.
Rt Hon Baroness Helene Hayman GBE, Recent Lord Speaker of the House of Lords, United Kingdom Parliament
Rt. Hon. Baroness Hayman has just completed a five year term as Lord Speaker of the House of Lords, the upper chamber of the United Kingdom parliament, where she had previously served as a Government Minister of State, but having begun her parliamentary career in the House of Commons in 1974.
Whilst raising a family in the intervening period, Helene Hayman was a member of the Royal College of Obstetricians and Gynaecologists’ Ethics Committee for fifteen years, and of the University College of London’s Committee on Ethics of Clinical Investigation. Former public service roles also include the inaugural Chairmanship of Cancer Research UK, the largest charity in the UK; and of the Human Tissue Authority, including membership of the Human Fertilisation and Embryology Authority; and whilst Lord Speaker, President of the Commonwealth Parliamentary Association.
Peter Hotez, MD, PhD, President and Ex Officio Trustee
Dr. Peter Hotez is President of the Sabin Vaccine Institute and leads the Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development in Houston, Texas. He also serves as the founding dean of a new School of Tropical Medicine at Baylor College of Medicine. His academic research focuses on vaccine development for a wide range of neglected tropical diseases around the globe.
Dr. Hotez serves President of the American Society of Tropical Medicine and Hygiene as Editor-in-Chief of PLoS Neglected Tropical Diseases. He graduated Phi Beta Kappa from Yale University in 1980 with a degree in Molecular Biophysics, and obtained both his M.D. and Ph.D. from the medical scientist-training program at Weill Cornell Medical College and The Rockefeller University in New York. Dr. Hotez is a member of the Institute of Medicine of the National Academy of Sciences.
Axel Hoos, MD, PhD, Medical Lead in Immunology/Oncology at Bristol-Myers Squibb
Dr. Axel Hoos is Medical Lead in Immunology/Oncology at Bristol-Myers Squibb. Dr. Hoos also serves as co-chair of the Executive Committee of the Cancer Vaccine Consortium of the New York-based Cancer Research Institute. In these capacities he is developing promising immunotherapies for life-threatening diseases and is spearheading innovative initiatives to foster the dialogue between regulatory, industry and academic stakeholders.
Prior to his current role, Dr. Hoos was Senior Director, Clinical Development at Antigenics Inc., a biotechnology company with focus on developing therapies for cancer and infectious diseases, where he was responsible for strategy and execution of clinical trials in all phases of product development. Dr. Hoos studied medicine at Heidelberg University, Heidelberg, Germany and received his Ph.D. in molecular oncology at the German Cancer Research Center in Heidelberg.
Michael W. Marine, Ambassador (ret.), Chief Executive Officer and Ex Officio Trustee
Michael W. Marine, former U.S. Ambassador to the Socialist Republic of Vietnam, was appointed as the new chief executive officer of the Sabin Vaccine Institute on April 28, 2010. Mr. Marine joined Sabin's leadership team in December 2009 after serving eight months on the Joint Action Committee of the Global Network for Neglected Tropical Diseases.
He was a member of the U.S. State Department’s Foreign Service for 32 years and served as U.S. Ambassador to the Socialist Republic of Vietnam from September 2004 to August 2007. Mr. Marine graduated Phi Beta Kappa and summa cum laude from the University of California at Santa Barbara in 1974 with a degree in Asian Studies. He entered the Foreign Service in 1975. He received the State Department’s Superior Honor Award six times.
Ciro de Quadros, MD, Executive Vice President and Ex Officio Trustee
Before joining the Sabin Vaccine Institute in 2003, Dr. de Quadros was Director of the Division of Vaccines and Immunization at the Pan American Health Organization. He also served as the World Health Organization's Chief Epidemiologist for the Smallpox Eradication Program in Ethiopia from 1970 to 1976.
Dr. de Quadros is a leader in the development of successful surveillance and containment strategies for the eradication of smallpox worldwide, and has directed successful polio and measles eradication efforts in the Americas. Dr. de Quadros serves as Associate Adjunct Professor at the Johns Hopkins School of Hygiene and Public Health in Baltimore, M.D.; and an Adjunct Professor in the Department of Tropical Medicine at The George Washington University School of Medicine and Health Sciences in Washington, DC. He completed his medical and public health studies in Brazil.
Kevin L. Reilly, Chairman of the Board of VaxGen, Inc.
Mr. Reilly is Chairman of the Board of VaxGen, Inc., a top bio-pharmaceutical company. From 1999 through 2002, Mr. Reilly was President of Wyeth Vaccines and Nutrition. Prior to joining the vaccine division, he was President of Wyeth Nutrition International where he directed the accelerated growth of Wyeth's worldwide vaccine and nutritional business.
He began his career at Connaught Laboratories, Ltd. as a Senior Vice President in charge of Canadian and export operations. Mr. Reilly earned a Bachelor of Science degree from the University of Melbourne in 1963 and a Master of Business Administration degree from York University, Toronto Canada in 1973. Mr. Reilly is also a 1981 graduate of the Advanced Management Program at Harvard Business School.
Gary Rosenthal, Partner in The Sterling Group, L.P.
Gary Rosenthal is a Partner in The Sterling Group, L.P., a private equity group headquartered in Houston, Texas. Previously, Mr. Rosenthal served as Executive Chairman or CEO of public and private companies and as a Partner in the Houston based law firm Vinson & Elkins. Mr. Rosenthal is a Director of Oil States International Incorporated. He is the Immediate Past Chairman of the Board of Trustees of Texas Children’s Hospital and a member of the board of Commentary magazine and of The University of St. Thomas. A native of Tulsa, Oklahoma, Mr. Rosenthal is an honors graduate of Harvard College and Harvard Law School and a former Charles Henry Fiske Scholar at Trinity College, Cambridge University.
Philip K. Russell, MD, Past Chairman, Major General, U.S. Army Medical Corps (Ret.)
Retired Major General Philip K. Russell, M.D. served in the U.S. Army Medical Corps from 1959 to 1990, pursuing a career in infectious disease and tropical medicine research. Dr. Russell contributed to the successful development of several vaccines important to the military and public health, including those of adenovirus, meningitis, and hepatitis A and B. Later, as director of the Walter Reed Army Institute of Research, he led research on vaccines against dengue and malaria.
Dr. Russell has worked closely with the World Health Organization as special advisor to the Children's Vaccine Initiative and was founding board member of the International AIDS Vaccine Initiative. He served as an advisor to the Bill and Melinda Gates Foundation as well as several vaccine programs and was instrumental in creating the Malaria Vaccine Initiative. Russell continues to be an integral part of the Albert B. Sabin Vaccine Institute and to work on the development of vaccines for the developing world.
Marc Shapiro, Non-Executive Chairman of Chase Bank of Texas
Peter L. Thoren, Executive Vice President of Access Industries
Mr. Thoren is Executive Vice President of Access Industries, a privately held, U.S.-based industrial group. He is active in numerous organizations focused on foreign policy and economics including the Center for National Policy, the Council on Foreign Relations, Business Executives for National Security, and The Economic Club of New York.
Before joining Access in 2001, Mr. Thoren held senior management positions with Salomon Inc and Walker Digital Corporation and practiced law at Rogers & Wells. Mr. Thoren also serves on the boards of the Center for National Policy, CIBAM at the Judge Business School (University of Cambridge), the US-Russia Business Council, and The Connecticut Appleseed Foundation and is a Fellow of the Foreign Policy Association.
Michael E. Whitham, Secretary and Treasurer, Founding partner of the law firm of Whitham, Curtis, Christofferson & Cook
Mr. Michael Whitham is a founding partner of the law firm of Whitham, Curtis, Christofferson & Cook in Reston, VA. He has represented individuals, non-profit organizations, universities, small and large corporations, international organizations and universities on intellectual property matters for more than twenty years.
Mr. Whitham has prosecuted and defended patent, trademark, and copyright infringement actions, as well as actions involving theft of trade secrets in Federal District Courts, and has represented clients in Appeals to the Court of Appeals for the Fourth Circuit and the Federal Circuit. Mr. Whitham has undergraduate and graduate degrees in biochemistry and chemistry, respectively, and received his law degree, with distinction from George Mason University in 1990.
Heloisa Sabin, Honorary Trustee
Mrs. Heloisa Sabin, who helped establish the Sabin Vaccine Institute in 1993, was unanimously elected Honorary Trustee on August 26, 2009. She has continuously championed the work and legacy of her late husband, Dr. Albert Sabin, by promoting the role of vaccines in eliminating needless deaths from preventable and treatable diseases.
Originally from Brazil, but currently residing in Washington, DC, Mrs. Sabin is a notable advocate for the vaccine and global health fields.